MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience Total Liabilities 2011-2026 | HBIO
Annual Total Liabilities Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.3 M | 63.3 M | 64.3 M | 73.1 M | 78.9 M | 79.6 M | 83.2 M | 85.9 M | 28.5 M | 35.6 M | 42.6 M | 40.4 M | 41 M | 29.3 M | 31.1 M | 34.5 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 85.9 M | 28.5 M | 54.9 M |
Quarterly Total Liabilities Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.9 M | 63.9 M | 64.4 M | 65 M | 63.3 M | 65.9 M | 61.7 M | 64.3 M | 64.3 M | 65.4 M | 67.5 M | 71.2 M | 73.1 M | - | - | 81.7 M | 78.9 M | 77 M | 75.3 M | 74.1 M | 79.6 M | 79.6 M | 79.6 M | 79.6 M | 83.2 M | 83.2 M | 83.2 M | 83.2 M | 85.9 M | 85.9 M | 85.9 M | 85.9 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 42.5 M | 42.5 M | 42.5 M | 42.5 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 41 M | 41 M | 40.7 M | 41 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M | 31.1 M | 31.1 M | 31.1 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 85.9 M | 28.5 M | 56.2 M |
Total Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
4.16 B | $ 59.77 | -1.01 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
17.9 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
308 M | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
867 M | $ 114.71 | 0.48 % | $ 3.67 B | USA |
 |
ICU Medical
ICUI
|
315 M | $ 118.86 | -3.36 % | $ 2.93 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
2.52 B | $ 422.51 | -1.3 % | $ 151 B | USA |
 |
Repro Med Systems
KRMD
|
11.2 M | $ 3.93 | -1.26 % | $ 182 M | USA |
 |
LeMaitre Vascular
LMAT
|
222 M | $ 96.95 | -2.56 % | $ 2.19 B | USA |
 |
Alcon
ALC
|
9.52 B | $ 63.77 | -0.39 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
1.57 B | $ 178.41 | 0.03 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.4 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.34 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
85.8 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.94 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
11.1 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.62 B | $ 23.53 | -1.34 % | $ 3.95 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
2.38 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
20.4 M | $ 6.0 | -6.69 % | $ 50.9 K | USA |
 |
Haemonetics Corporation
HAE
|
680 M | $ 56.46 | -1.16 % | $ 2.84 B | USA |
 |
STAAR Surgical Company
STAA
|
107 M | $ 32.48 | 1.47 % | $ 1.61 B | USA |
 |
STERIS plc
STE
|
3.53 B | $ 211.95 | -1.87 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
59.9 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
479 M | $ 142.49 | 0.23 % | $ 6.9 B | USA |
 |
Teleflex Incorporated
TFX
|
3.82 B | $ 130.03 | -0.19 % | $ 5.8 B | USA |
 |
InfuSystem Holdings
INFU
|
43.2 M | $ 8.69 | 0.93 % | $ 180 M | USA |
 |
Microbot Medical
MBOT
|
3.99 M | $ 1.89 | 1.89 % | $ 86.5 M |  Israel |
 |
Milestone Scientific
MLSS
|
4.99 M | $ 0.33 | -2.89 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
1.1 B | $ 61.38 | -1.89 % | $ 3.63 B | USA |
 |
Utah Medical Products
UTMD
|
3.27 M | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
1.09 B | $ 302.74 | 0.85 % | $ 21.9 B | USA |
 |
Pulse Biosciences
PLSE
|
13.9 M | $ 24.3 | -10.33 % | $ 1.64 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
4.09 B | $ 9.96 | -4.32 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
68.3 M | $ 0.67 | -3.06 % | $ 20.1 M | USA |
 |
Pro-Dex
PDEX
|
24.6 M | $ 59.69 | 1.77 % | $ 196 M | USA |
 |
Predictive Oncology
POAI
|
5.17 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
34 M | $ 20.35 | -3.37 % | $ 972 M | USA |
 |
Stereotaxis
STXS
|
33.5 M | $ 1.88 | -3.6 % | $ 171 M | USA |
 |
Baxter International
BAX
|
14 B | $ 17.3 | -2.76 % | $ 8.87 B | USA |
 |
ResMed
RMD
|
1.74 B | $ 202.01 | -0.22 % | $ 29.5 B | USA |
 |
AtriCure
ATRC
|
162 M | $ 27.98 | -0.6 % | $ 1.34 B | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
97.2 M | $ 10.84 | -1.72 % | $ 443 M | USA |
 |
Becton, Dickinson and Company
BDX
|
30.7 B | $ 143.06 | -0.98 % | $ 41.2 B | USA |
 |
Nephros
NEPH
|
3.44 M | $ 3.17 | -5.11 % | $ 33.6 M | USA |
 |
OraSure Technologies
OSUR
|
62.3 M | $ 3.07 | 3.9 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
844 M | $ 104.6 | 1.18 % | $ 5.88 M | USA |